Introduction and Objective: Continuous glucose monitors (CGMs) and insulin pumps improve glycemic control and quality of life in type 1 diabetes (T1D) patients. We sought patient-reported reasons for not using CGMs or pumps. Methods: Anonymous surveys were administered to patients with a diagnosis of T1D for ≥6 months in a pediatric diabetes clinic between 9/25-11/25 who were not using a pump or CGM. Surveys collected self-reported duration of T1D, HbA1c range, pump/CGM information sources, and reasons for nonuse of diabetes technology. Data was analyzed with descriptive statistics and Fisher's exact test. Results: A total of 34 surveys were completed (7 CGM, 27 pump). Years since T1D diagnosis differed significantly between CGM and pump nonusers (p=0.02); 100% of CGM nonusers had 5 years since diagnosis versus 44% of pump nonusers with ≤5 years. Table 1 describes reasons for nonuse of technology. Of the 7 CGM survey respondents, 5 previously wore a CGM. Most pump survey respondents (96%) had never used a pump. Information on pumps was received by 96% of respondents, most often from the medical team (96%). Conclusion: Wearability/aesthetics was the most common reason for nonuse of both pumps and CGMs, followed by lack of trust in technology. Early discussion of pump benefits and patient concerns may build trust as 44% of pump nonusers had diabetes ≤ 5 years and most learned about pumps from our medical team. Enhanced clinic processes may address other barriers such as accessibility and clinic expectations. Disclosure E. Slattery: None. C. Kaeppler: None. P. Wolfgram: None. K. Yan: None. M.A. Liegl: None.
SLATTERY et al. (Fri,) studied this question.